Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 2) [2011] FCA 213

Sanofi-Aventis Australia Pty Ltd v Apotex Pty Ltd (No 2) [2011] FCA 213

The amendments sought by the respondent, though late, should be allowed as any potential prejudice to the applicants was speculative and outweighed by the prejudice to the respondent if leave was refused; the amendments were not hypothetical, redundant, or futile to the degree requiring refusal, and the applicants had not demonstrated concrete prejudice.

Jurisdiction
Australia
Judgment Date
07 March 2011
Procedural Posture
Application for Leave to Amend Defence and Cross Claim / Interlocutory Motion (pre Trial)
Outcome
Leave to amend granted
Legal Topics
['pleadings Amendment' 'patent Invalidity' 'particulars of Invalidity' 'leave to Amend' 'hypothetical Issues']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Application for Leave to Amend Defence and Cross Claim / Interlocutory Motion (pre Trial)

  1. 1 ['Whether leave should be granted to Apotex Pty Ltd to file a Second Further Amended Defence and Cross-Claim and Further Amended Particulars of Invalidity.' 'Whether the proposed amendments raise hypothetical issues or are redundant, obscure or prejudicial to the applicants.']

Ratio Decidendi

The amendments sought by the respondent, though late, should be allowed as any potential prejudice to the applicants was speculative and outweighed by the prejudice to the respondent if leave was refused; the amendments were not hypothetical, redundant, or futile to the degree requiring refusal, and the applicants had not demonstrated concrete prejudice.

Court Disposition

Leave to amend granted

Orders

  • ['The respondent/cross-claimant be granted leave to file a Second Further Amended Defence and Cross-Claim and Further Amended Particulars of Invalidity in substantially the form annexed to its Notice of Motion dated 21 February 2011.' 'The respondent/cross-claimant pay any costs of the applicants/cross-respondents...